Gohar Mushtaq
TitleCited byYear
Inflammatory process in Alzheimer’s and Parkinson's diseases: central role of cytokines
Q Alam, M Zubair Alam, G Mushtaq, G A Damanhouri, M Rasool, ...
Current pharmaceutical design 22 (5), 541-548, 2016
882016
Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus
G Mushtaq, N H Greig, J A Khan, M A Kamal
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014
742014
Alzheimer’s disease and type 2 diabetes via chronic inflammatory mechanisms
G Mushtaq, JA Khan, TA Kumosani, MA Kamal
Saudi journal of biological sciences 22 (1), 4-13, 2015
422015
The diabetic brain and cognition
P Riederer, AD Korczyn, SS Ali, O Bajenaru, MS Choi, M Chopp, ...
Journal of Neural Transmission 124 (11), 1431-1454, 2017
362017
Clinical biomarkers in sickle cell disease
GA Damanhouri, J Jarullah, S Marouf, SI Hindawi, G Mushtaq, MA Kamal
Saudi journal of biological sciences 22 (1), 24-31, 2015
362015
miRNAs as circulating biomarkers for Alzheimer’s disease and Parkinson’s disease
G Mushtaq, N H Greig, F Anwar, M A Zamzami, H Choudhry, M M Shaik, ...
Medicinal Chemistry 12 (3), 217-225, 2016
282016
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens
MJ Pucci, J Cheng, SD Podos, CL Thoma, JA Thanassi, DD Buechter, ...
Antimicrobial agents and chemotherapy 51 (4), 1259-1267, 2007
272007
Solid matrix based lipidic nanoparticles in oral cancer chemotherapy: applications and pharmacokinetics
J Ahmad, S Amin, M Rahman, R Abdur Rub, M Singhal, M Zaki Ahmad, ...
Current drug metabolism 16 (8), 633-644, 2015
252015
Role of graphene nano-composites in cancer therapy: theranostic applications, metabolic fate and toxicity issues
M Rahman, M Zaki Ahmad, J Ahmad, J Firdous, F Jalees Ahmad, ...
Current drug metabolism 16 (5), 397-409, 2015
222015
Alkaloids: an emerging antibacterial modality against methicillin resistant Staphylococcus aureus
A Pervaiz, R Khan, F Anwar, G Mushtaq, M A Kamal, H Khan
Current pharmaceutical design 22 (28), 4420-4429, 2016
212016
Neuroprotective mechanisms mediated by CDK5 inhibition
G Mushtaq, N H Greig, F Anwar, F A Al-Abbasi, M A Zamzami, ...
Current pharmaceutical design 22 (5), 527-534, 2016
212016
Current understanding of HSP90 as a novel therapeutic target: An emerging approach for the treatment of cancer
A Haque, Q Alam, M Zubair Alam, E I Azhar, K Hussain Wali Sait, ...
Current pharmaceutical design 22 (20), 2947-2959, 2016
202016
Recent updates on the association between Alzheimer’s disease and vascular dementia
G M Ashraf, S Chibber, S K Zaidi, S Tabrez, A Ahmad, S Shakil, ...
Medicinal Chemistry 12 (3), 226-237, 2016
192016
Applications of Nanotechnology in Diagnostics and Therapeutics of Alzheimer’s and Parkinson’s Disease
G Soursou, A Alexiou, G Md Ashraf, A Ali Siyal, G Mushtaq, M A Kamal
Current drug metabolism 16 (8), 705-712, 2015
192015
Biological mechanisms linking Alzheimer’s disease and type-2 diabetes mellitus
G Mushtaq, J A Khan, M A Kamal
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014
182014
In silico analysis of green tea polyphenols as inhibitors of AChE and BChE enzymes in Alzheimer’s disease treatment
B Ali, Q MS Jamal, S Shams, N A Al-Wabel, M U Siddiqui, M A Alzohairy, ...
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2016
172016
Psychopharmacology of attention-deficit hyperactivity disorder: effects and side effects
J Golmirzaei, H Mahboobi, M Yazdanparast, G Mushtaq, M A Kamal, ...
Current pharmaceutical design 22 (5), 590-594, 2016
172016
Nanoparticles, neurotoxicity and neurodegenerative diseases
G Mushtaq, J A Khan, E Joseph, M A Kamal
Current drug metabolism 16 (8), 676-684, 2015
172015
Current challenges to overcome in the management of type 2 diabetes mellitus and associated neurological disorders
N M Khan, A Ahmad, R K Tiwari, M A Kamal, G Mushtaq, G M Ashraf
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014
172014
Inhibition on the growth of human MDA-MB-231 breast cancer cells in vitro and tumor growth in a mouse xenograft model by Se-containing polysaccharides from Pyracantha fortuneana
C Yuan, C Wang, J Wang, V Kumar, F Anwar, F Xiao, G Mushtaq, Y Liu, ...
Nutrition Research 36 (11), 1243-1254, 2016
152016
The system can't perform the operation now. Try again later.
Articles 1–20